Shimei Baifu Ning (时美百服咛)时美百服咛
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 中美上海施贵宝制药有限公司Chinese legal name: 中美上海施贵宝制药有限公司
主要成分Active Ingredients
- 伪麻黄碱Weima Huangjian
- 时美百服咛为复方制剂Recorded Chinese composition: 时美百服咛为复方制剂
药物知识说明
伪麻黄碱是一种在国家药监局注册认定的药品。该药品含有伪麻黄碱-34ee3fb7等成分。
该药品关联的活性成分包括：伪麻黄碱Weima Huangjian。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：中美上海施贵宝制药有限公司Chinese legal name: 中美上海施贵宝制药有限公司。
您可以探索含有相同成分的其他药品：伪麻黄碱-34ee3fb7成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 时美百服咛) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 伪麻黄碱Weima Huangjian.
Manufacturers recorded for this product: 中美上海施贵宝制药有限公司Chinese legal name: 中美上海施贵宝制药有限公司.
Explore other medicines containing the same ingredient: 伪麻黄碱 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 时美百服咛Recorded Chinese name: 时美百服咛
- 规格Specification: 15ml/ 瓶，塑料瓶装，带有儿童保险盖和滴管。Recorded Chinese composition: 15ml/ 瓶，塑料瓶装，带有儿童保险盖和滴管。
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 中美上海施贵宝制药有限公司Chinese legal name: 中美上海施贵宝制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H10970427
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H10970427
Manufacturer
Chinese legal name: 中美上海施贵宝制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H10970427
生产企业
中美上海施贵宝制药有限公司(国产)
适应症
本品适用于婴儿因感冒及其他上呼吸道过敏性疾病等引起的多种症状、如发热、鼻塞、流涕等。
用法用量
口服，每4～6小时可重复用药，每24小时不超过4次。
不良反应
偶有口干、胃部不适、皮疹等轻微症状，停药后可自行消失。
禁忌
1. 对时美百服咛过敏及对其他解热镇痛药过敏者禁用。2. 当本品性状发生改变时禁用。
注意事项
1. 服药3日后持续发热，请咨询医师。2. 有严重反应时，请即去医院就医。
贮藏
密封
规格
15ml/ 瓶，塑料瓶装，带有儿童保险盖和滴管。
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.